Please login to the form below

Not currently logged in
Email:
Password:

Dominic Moorhead joins Ferring Pharmaceuticals

He takes up executive VP and chief financial officer role

Dominic MoorheadSwitzerland-based Ferring Pharmaceuticals has appointed Dominic Moorhead as its new executive vice president and chief financial officer.

Following a three-month transition period, Moorhead will assume full responsibility for the Finance, Corporate Information Systems and International Audit functions.

With over 30 years experience in the life sciences industry, Moorhead has held a number of senior roles such as strategic advisor to executives and investors in biotech, global financial controller for Takeda Pharmaceuticals, and CFO of the international business following the acquisition of Nycomed.

Prior to this, he served Hoffman- La Roche (Roche) where he was CFO of its pharma division for nine years.

Michel Pettigrew, president of the executive board and chief operating officer of Ferring, said: “His extensive experience and perspectives in finance, business and strategic development in the pharmaceutical sector make him a great fit for Ferring as we continue on our strong growth path.”

Moorhead succeeds Peter Wilden who will still continue to represent Ferring on a number of additional boards.

5th April 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics